Sampre Nutrition

  • Market Cap: Micro Cap
  • Industry: FMCG
  • ISIN: INE375C01022
  • NSEID:
  • BSEID: 530617
INR
4.01
-0.21 (-4.98%)
BSENSE

Nov 20

BSE+NSE Vol: 7.72 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 981259,
    "name": "Sampre Nutrition",
    "stock_name": "Sampre Nutrition",
    "full_name": "Sampre Nutritions Ltd",
    "name_url": "stocks-analysis/sampre-nutrition",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "4.01",
    "chg": -0.21,
    "chgp": "-4.98%",
    "dir": -1,
    "prev_price": "4.22",
    "mcapval": "40.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530617,
    "symbol": "",
    "ind_name": "FMCG",
    "ind_code": 31,
    "indexname": "",
    "isin": "INE375C01022",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "7.72 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/sampre-nutrition-981259-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sampre Nutritions Ltd Falls 9.07%: Valuation Shifts Amid Weak Fundamentals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sampre-nutritions-ltd-falls-907-valuation-shifts-amid-weak-fundamentals-4270451",
        "imagepath": "",
        "date": "2026-11-21 14:03:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Nov:</strong> Stock opens at Rs.4.42, slight gain of 0.23%</p>\n                    <p><strong>17 Nov:</strong> MarketsMOJO upgrades rating to Sell; stock drops 4.75%</p>\n                    <p><strong>18 Nov:</strong> Stock rebounds 3.56% on improved valuation news</p>\n                    <p><strong>19 Nov:</strong> Valuation grade shifts from very attractive to attractive; stock falls 3.21%</p>\n                    <p><strong>20 Nov:</strong> Week closes at Rs.4.01, down 4.98% on heavy volume</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.4.41</div><..."
      },
      {
        "title": "Sampre Nutritions Ltd Valuation Improves Amid Persistent Market Challenges",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sampre-nutritions-ltd-valuation-improves-amid-persistent-market-challenges-4267396",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SampreNutrition_valuationdot_4267396.png",
        "date": "2026-11-19 08:00:52",
        "description": "Sampre Nutritions Ltd, a micro-cap player in the FMCG sector, has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating. This change reflects evolving market perceptions amid persistent challenges in financial performance and stock returns, offering investors a nuanced view of price attractiveness relative to historical and peer benchmarks."
      },
      {
        "title": "Sampre Nutritions Ltd Upgraded to Sell on Improved Valuation and Financial Trends",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/sampre-nutritions-ltd-upgraded-to-sell-on-improved-valuation-and-financial-trends-4266394",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SampreNutrition_mojoScore_4266394.png",
        "date": "2026-11-18 08:37:43",
        "description": "Sampre Nutritions Ltd, a micro-cap player in the FMCG sector, has seen its investment rating upgraded from Strong Sell to Sell as of 17 Nov 2026. This change is primarily driven by a marked improvement in valuation metrics, even as the company continues to grapple with weak financial trends and subpar quality indicators. The stock’s recent performance and technical outlook also influenced the revised assessment, reflecting a nuanced view of its prospects amid challenging market conditions."
      },
      {
        "title": "Sampre Nutritions Gains 1.85%: 3 Key Factors Driving the Week’s Mixed Moves",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sampre-nutritions-gains-185-3-key-factors-driving-the-weeks-mixed-moves-4261752",
        "imagepath": "",
        "date": "2026-11-14 14:00:37",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>09 Nov:</strong> Stock hits 52-week low at Rs.4.00</p>\n                    <p><strong>12 Nov:</strong> Downgrade to Strong Sell by MarketsMOJO</p>\n                    <p><strong>13 Nov:</strong> Valuation rating shifts from very attractive to attractive</p>\n                    <p><strong>13 Nov:</strong> Week closes at Rs.4.41 (+1.85%) outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.4.33</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.4.41</div><div class=\"stat..."
      },
      {
        "title": "Sampre Nutritions Ltd Downgraded to Strong Sell Amid Mixed Financial and Valuation Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/sampre-nutritions-ltd-downgraded-to-strong-sell-amid-mixed-financial-and-valuation-signals-4260231",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SampreNutrition_mojoScore_4260231.png",
        "date": "2026-11-13 08:37:39",
        "description": "Sampre Nutritions Ltd, a micro-cap player in the FMCG sector, has seen its investment rating upgraded from Sell to Strong Sell as of 12 Nov 2026, driven primarily by an improvement in valuation metrics. Despite this upgrade, the company continues to face significant challenges in financial trends and quality parameters, reflecting a complex investment outlook amid a volatile market environment."
      },
      {
        "title": "Sampre Nutritions Ltd Valuation Shifts Amidst Challenging Market Performance",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sampre-nutritions-ltd-valuation-shifts-amidst-challenging-market-performance-4259922",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SampreNutrition_valuationdot_4259922.png",
        "date": "2026-11-13 08:01:18",
        "description": "Sampre Nutritions Ltd, a micro-cap player in the FMCG sector, has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive price level. Despite this improvement, the company continues to face significant headwinds, reflected in its weak returns and a recent downgrade to a Strong Sell rating by MarketsMOJO. This article analyses the evolving valuation landscape of Sampre Nutritions, comparing key metrics against historical averages and peer benchmarks to assess its price attractiveness and investment prospects."
      },
      {
        "title": "Sampre Nutritions Ltd Falls to 52-Week Low of Rs 4 as Sell-Off Deepens",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sampre-nutritions-ltd-stock-hits-52-week-low-at-rs4-amidst-weak-long-term-metrics-4256719",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SampreNutrition_priceRelatedfactors_4256719.png",
        "date": "2026-11-09 10:11:08",
        "description": "A steep decline of 88.02% over the past year has dragged Sampre Nutritions Ltd to a fresh 52-week low of Rs 4 on 09 Nov 2026, marking a significant underperformance against the Sensex’s modest 2.9% fall in the same period."
      },
      {
        "title": "Sampre Nutritions Ltd Falls to 52-Week Low of Rs 4.49 as Sell-Off Deepens",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sampre-nutritions-ltd-hits-52-week-low-amidst-continued-downtrend-4242309",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SampreNutrition_priceRelatedfactors_4242309.png",
        "date": "2026-10-28 12:12:45",
        "description": "A sharp decline has pushed Sampre Nutritions Ltd to a fresh 52-week low of Rs 4.49 on 28 Oct 2026, marking a significant 88.5% drop over the past year despite some recent financial improvements."
      },
      {
        "title": "Sampre Nutritions Ltd is Rated Sell by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/sampre-nutritions-ltd-is-rated-sell-by-marketsmojo-4241857",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SampreNutrition_mojoScore_4241857.png",
        "date": "2026-10-28 10:10:44",
        "description": "Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 28 October 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance."
      }
    ],
    "total": 45,
    "sid": "981259",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/sampre-nutritions-981259"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "09-Nov-2026",
      "details": "Intimation of unaudited standalone and consolidation results for the second quarter ended 30 September 2026 in the newspaper.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Unaudited Financial Results For The Second Quarter Ended 30 September 2026",
      "datetime": "06-Nov-2026",
      "details": "In compliance with Regulation 33 of the SEBI (LODR) Regulations 2015 the unaudited standalone and consolidated financial results along with the limited review report is attached for the second quarter ended 30 September 2026 for the financial year 2026-27.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Approving Q2 Results For The Quarter Ended 30 September 2026",
      "datetime": "02-Nov-2026",
      "details": "Sampre Nutritions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 inter alia to consider and approve unaudited standalone and consolidated financial results of the Company for the second quarter ended 30 September 2026 for the financial year 2026-27.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sampre Nutritions Ltd has announced <strong>5:10</strong> stock split, ex-date: 14 Nov 25",
          "dt": "2025-11-14",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Sampre Nutritions Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 14 Nov 25",
          "dt": "2025-11-14",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

09-Nov-2026 | Source : BSE

Intimation of unaudited standalone and consolidation results for the second quarter ended 30 September 2026 in the newspaper.

Board Meeting Outcome for Unaudited Financial Results For The Second Quarter Ended 30 September 2026

06-Nov-2026 | Source : BSE

In compliance with Regulation 33 of the SEBI (LODR) Regulations 2015 the unaudited standalone and consolidated financial results along with the limited review report is attached for the second quarter ended 30 September 2026 for the financial year 2026-27.

Board Meeting Intimation for Approving Q2 Results For The Quarter Ended 30 September 2026

02-Nov-2026 | Source : BSE

Sampre Nutritions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 inter alia to consider and approve unaudited standalone and consolidated financial results of the Company for the second quarter ended 30 September 2026 for the financial year 2026-27.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Sampre Nutritions Ltd has announced 5:10 stock split, ex-date: 14 Nov 25

stock-summary
BONUS

Sampre Nutritions Ltd has announced 1:1 bonus issue, ex-date: 14 Nov 25

stock-summary
RIGHTS

No Rights history available